Myotonic Dystrophy
Myotonic Dystrophy is a genetic disorder that affects muscle function, leading to symptoms such as muscle weakness, stiffness, and difficulty relaxing muscles after use.
We are comparing two forms of mexiletine to see which one is safer and more effective for adults with non-dystrophic myotonias. This study aims to improve treatment options for conditions like myotonia congenita and paramyotonia congenita.
Health conditions and diseases that the clinical trial is designed to study and treat.
Myotonic Dystrophy is a genetic disorder that affects muscle function, leading to symptoms such as muscle weakness, stiffness, and difficulty relaxing muscles after use.
Non-Dystrophic Myotonias (NDM) are a group of genetic muscle disorders characterized by muscle stiffness and delayed relaxation after contraction, without the muscle degeneration seen in dystrophic conditions.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.